Critical Illness

Annual Financial Report of the Group for the year 2018
Announcement of the date for examination of the Audited Financial Statements of the Group for the year ended 31 December 2018
Successful Completion of Capital Increase and Listing of New Ordinary Shares
Successful Share Capital Increase of €150m
Dispatch of the Allotment Letters
ECB approves inclusion of 3Q2018 profit, including negative goodwill, in the Group's regulatory capital
Voluntary Conversion of Contingent Capital Securities 2 (“CCS 2”) into shares
Voluntary Conversion of Contingent Capital Securities 1 (“CCS 1”) into shares
Share Capital Increase - Approval and Publication of Prospectus
Capital Raise - Update on investor subscription agreements
Financial Results of the Group 9M 2018
Period and procedure of voluntary conversion of the contigent capital securities 1 ("CCS 1")
Period and procedure of voluntary conversion of the contigent capital securities 2 ("CCS 2")
Date of announcement of Financial Results for the nine-month period ended 30/09/2018
Mastercard Rally
Trading update for the financial results for the nine-month period ended 30 September 2018
Announcement for COBALT
New overdraft facilities transferred to Hellenic Bank
Financial Results of the Group 6M 2018
Completion of Acquisition of Assets and Liabilities of the CCB
Date of the Board Meeting for Half Year 2018 Results
Decisions of the EGM
Re-composition of the existing Committees
Subscription agreement with Emma Alpha Holding Ltd
Notice for Extraordinary General Meeting
Establishment of Integration Committee of the BoD
Commission for the Protection of Competition Decision
Decisions of BoD after the 44th AGM
Decisions of the 44th AGM
Withdrawal of candidacy for re-election as Member of BOD
Proxy to Mr. Nicos Michaelas and Mr. Varnavas Irinarchos for DEMETRA INVESTMENT PUBLIC LTD
CSR Report of Hellenic Bank for 2017
Agreement to acquire certain assets and liabilities of the CCB
Proxy to Mr. Nicolaos Pelides for THIRD POINT HELLENIC RECOVERY FUND L.P
Notice for the Annual General Meeting
Acceptance of Hellenic Bank's final offer
Submission of Final Offer
Voluntary Conversion of the CCS1 & CCS2
Completion of the disposal of a portfolio of NPLs
Financial Results of the Group 3M 2018
Notice for Extraordinary General Meeting and Proxy Form
Date of the Board Meeting examining Q1 Results
Submission of Offer through Tender Process
Disclosure of Information under Pillar ΙΙΙ of Basel III
Date of the 44th Annual General Meeting
Report of the BoD on Corporate Governance for 2017
Disclosure of Information under Pillar III of Basel III for the year 2018
Annual Report for 2017
Participation in Tender Process 2
Information from the Issuer Company on the acquisition or disposal by a major shareholder
Report of the BoD on Corporate Governance for the year 2018
Date of the 45th AGM of the Shareholders
Participation in Tender Process
Annual Financial Report for 2017
Date of the 44th Annual General Meeting
Date of the Board Meeting for the examination of the Audited Financial Statements
Premilimary Results for 2017
Date of the Board Meeting regarding Premilimary Results
Appointment of new Executive Officer
Agreement between Hellenic Bank and EBRD
Agreement to sell a portfolio of non-performing loans
Completion of Voluntary Early Exit Scheme
Voluntary Conversion CCS1 and CCS2
Έχεις τη δύναμη

Agreement HB - CCB

New overdraft facilities transferred to Hellenic Bank
Completion of Acquisition of Assets and Liabilities of the CCB
Agreement to acquire certain assets and liabilities of the CCB
Acceptance of Hellenic Bank's final offer
Submission of Final Offer

Recognition

Our Awards

News & Insights /portalserver/hb-en-portal/en/about-us/news--insights

Need to speak to somebody

Customer suggestions and complaints
Book an appointment

Help me with ...

Our locations /portalserver/hb-en-portal/en/about-us/our-locations

Personal Banking
Insure
Life insurance
Critical Illness

Hellenic Alico Life

Critical Illness and Permanent Total Disability Plan

Get immediate cover when you need it.

Key features and benefits

Low premium

Monthly premium payment with direct debit

Fast and simple procedures to join

Show all features

Dread diseases covered:

Cancer

Heart Attack / Myocardial Infraction

Kidney Failure

Stroke

Coronary Artery Bypass Grafting

Aorta Surgery

Blindness

Heart Valve Surgery

Major Organ Transplant

Paralysis

Benign Brain Tumour

Encephalitis

Coma

Loss of Limbs

Severe Burns

Parkinson’s Disease

Loss of Hearing

Loss of Speech

Bacterial Meningitis

Fulminant Hepatitis

Permanent Total Disability due to Disease or Accident

Age at entry: 18-55 (age at last birthday)

Duration: renewable until the 65th year insured

Key features

In the case of diagnosis (or operations due to) one of the twenty dread diseases listed, or permanent total disability, the insured individual will collect:

Premium: €10 monthly - Cover: €15.000
Premium: €20 monthly - Cover: €30.000
Medical Examinations: Not necessary